Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001461041 | SCV001664925 | likely benign | Familial cancer of breast; Fanconi anemia complementation group J | 2024-08-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002439094 | SCV002752434 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-05-19 | criteria provided, single submitter | clinical testing | The p.K979R variant (also known as c.2936A>G), located in coding exon 19 of the BRIP1 gene, results from an A to G substitution at nucleotide position 2936. The lysine at codon 979 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV003463043 | SCV004217096 | uncertain significance | Familial cancer of breast | 2023-06-02 | criteria provided, single submitter | clinical testing |